期刊文献+

CpG-ODN联合HBsAg体外对慢性乙肝患者外周血树突状细胞STAT、SOCS通路的影响 被引量:2

Effect of CpG-ODN combined with HBsAg on the intracellular signaling pathway of monocyte-derived dendritic cell from chronic hepatitis B patients
原文传递
导出
摘要 目的研究含非甲基化CpG基序的免疫刺激寡核苷酸(CpG-ODN)联合重组HBsAg对慢性乙肝(CHB)患者外周血树突状细胞(dendriticcell,DC)表面标志、功能及胞浆信号传导与转录激活因子(STAT)、细胞信号转导抑制因子(SOCS)表达的影响。方法由CHB患者和健康者外周血单核细胞诱导扩增DC,以CpG2ODN或联合HBsAg刺激DC,并与TNF2α比较,评价其对DC表面标志、分泌IL212p70及刺激同种T细胞增殖能力的影响;应用Westernblot法检测DC胞浆STAT1、3、4、5、6以及SOCS1、3蛋白的表达。结果与PBS组比,TNF2α、CpG-ODN或联合HBsAg能明显提高CHB患者DC表面分子HLA-DR表达,IL-12p70分泌增加,刺激同种T细胞增殖能力增强,CpG-ODN联合HBsAg还能明显提高CD1a的表达;CpG-ODN或联合HBsAg、TNF2α对DC胞浆STAT1、4、6和SOCS1、3的表达呈不同程度增强作用,对STAT3、5的表达无明显影响。结论CpG-ODN与TNF-α一样能促进CHB外周血DC分化、成熟;CpG2ODN或联合HBsAg能增强DC的特异性抗原提呈作用;其作用机制可能是通过调节DC细胞内STAT1、4、6以及SOCS1、3等信号蛋白的表达。 Objective To investigate the effect of synthetic nonmethylated CpG containing oligodeoxynu-eleotide(CpG-ODN) combined with recombined HBsAg polypepfide on the intracellular signaling pathways of monocyte-derived dendritic eells(DC) in patients with chronic hepatitis B(CHB). Methods Purified monocytes were isolated from the peripheral blood of CHB and healthy volunteers by combination of HISTOPAQUE-1.077 and CD14 Mien)Beads. Cells were collected for detection of surface molecules(HLA-DR/CD86/CD1a), IL-12 p70 levels in the supernatant and of stimulating capacity to allogenie T lymphocytes. The expression of signaling molecules, activators of transcription(STAT1, 3, 4, 5, 6) and suppressors of cell signaling(SOCS1, 3) in DC were detected by Western blot assay. Results As compared to control group, the expression rates of HLA-DR of DC in CHB with the group of CpG-ODN or group combined with HBsAg were obviously increased; both IL-12 p70 level and the stimulating capacity of DC to allogenic T lymphocytes were significantly improved in CpG-ODN group and CpG-ODN/HBsAg combination group( P〈0.01 and 0.05, respectively) ; in particular, the expression of CDla increased only in the CpG-ODN/HBsAg combination group. As compared to increased control group, both CpG-ODN (or combined with HBsAg) and TNF-α enhanced the expression of cytoplasmic phosphorylated STAT1, 4, 6 and SOCS1, 3 in DC of CHB, but have no effect on expression of STAT3, 5. Conclusion CpG-ODN(or combined with HBsAg), like TNF-α, has remarkable stimulatory effect to the impaired phenotype and function of monocyte-derived DC in patients with chronic hepatitis B possibly through regulating the expression of signal molecules of STAT1, 4, 6 and SOCS1, 3 in DC.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2005年第11期919-922,共4页 Chinese Journal of Microbiology and Immunology
基金 上海市科委科研计划项目资助(044119624)
关键词 慢性乙型肝炎 树突状细胞 非甲基化CpG寡核苷酸 乙型肝炎表面抗原 信号转导 Chronic hepatitis B Dendritic cell CpG containing oligodeoxynucleotide Hepatitis B surface antigen Signal transduction
  • 相关文献

参考文献12

  • 1Van der Molen RG, Sprengers D, Binda R, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology, 2004, 40(3): 738-746.
  • 2Gursel M, Verthelyi D, Klinman DK. CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells. Eur J Immunol, 2002, 32 (10): 2617-2622.
  • 3Merad M, Sugie T, Engleman EG, et al. In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood, 2002, 99(5): 1676-1682.
  • 4Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cell from human blood. An improves method with special regard to clinical applicability. J Immunol Method, 1996, 196(2): 137-151.
  • 5Vicari AP, Chiodoni C, Vaure C, et al. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med, 2002, 196: 541-549.
  • 6Ballas ZK, Krieg AM, Warren T, et al. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol, 2001, 167(8): 4878-4886.
  • 7Jackson SH, Yu CR, Mahdi RM, et al. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokines signaling. J Immunol, 2004, 172(4): 2307-2315.
  • 8Takauji R, Iho S, Takatsuka H, et al. CpG-DNA induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J Leukoc Biol, 2002, 72(5): 1011-1019.
  • 9Arbuthnot P, Capovilla A, Kew MC. Putative role of hepatitis B virus X protein in hepatocarcinogenesis; effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol, 2000, 15(4): 357-368.
  • 10Feim MH. Intracellular signaling and antiviral effects of interferons. Dig Liver Dis, 2000, 32(3): 257-263.

二级参考文献18

  • 1Takano S, Yokosuka O, Imazeki F, et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology, 1995, 21:650-655.
  • 2Ciurea A, Klenerman P, Hunziker L, et al. Viral persistence in vivo through selection of neutralizing antibody-escape variants. Proc Natl Acad Sci U S A, 2000, 97:2749-2754.
  • 3Gerlach JT, Diepolder HM, Jung MC, et al. Recurrence of hepatitis C virus after loss of virus- specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology, 1999, 117:933- 941.
  • 4Pittet MJ, Speiser DE, Valmori D, et al. Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHCrpeptide tetramers in cancer patients. Int Immunopharmacol, 2001, 1:1235-1247.
  • 5Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science, 1996, 274:94-96.
  • 6Piao WH, Song XG, Liu MC, et al. Clonging, expression, and purification of HLA-A2-BSP and beta-2m in Escherichia coli. Protein Expr Purif, 2004, 35:210-217.
  • 7Penna A, Chisari FV, Bertoletti A, et al. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med, 1991, 174:1565-1570.
  • 8Klenerman P, Cerundolo V, Dunbar P R.Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol, 2002, :263-272.
  • 9Sato Y, Sahara H, Tsukahara T, et al. Improved generation of HLA class I/peptide tetramers. J Immunol Methods, 2002, 271:177-184.
  • 10Ogg GS, McMichael AJ. Quantitation of antigen-specific CD8+ T-cell responses. Immunol Lett, 1999, 66:77-80.

共引文献34

同被引文献30

  • 1陈军浩,吴超,欧阳建,刘勇,耿东进.CpG寡核苷酸对人外周血B淋巴细胞免疫刺激作用[J].现代检验医学杂志,2006,21(4):1-3. 被引量:5
  • 2Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice [J]. J Exp Med, 1973, 137(5): 1 142-1 162.
  • 3Pillarisetty VG, Shah AB, Miller G, et al. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition [J]. J Immunol,2004, 172(2): 1 009-1 017.
  • 4Lau AH, Thomson AW. Dendritic cells and immune regulation in the liver. Gut,2003, 52(2): 307-314.
  • 5Sumpter TL, Abe M, Tokita D,et al. Dendritic cells, the liver, and transplantation[J]. Hepatology 2007, 46(6):2 021-2 031.
  • 6Jarnjak Jankovic S , Saeboe Larssen S , Kvalheim G, et al. mRNA transfection of DC in the immature or mature state : comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA [J]. Cytotherapy,2007,9(6) : 587-592.
  • 7Sousa Canavez JM, Canavez FC, Leite KR, et al. Therapeutic Dendritic cell vaccine preparation using tumor RNA transfec- tion: A promise approach to treat prostate cancer [J]. Genet Vaccines Ther, 2008,6 ( 1 ) : 2.
  • 8Royer PJ , Bougras G, Ebstein F, et al. Efficient monocyted- erived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: Application to active immunotherapy[J]. Exp Hematol,2008,36(3) : 329-339.
  • 9Henri S, Vremec D, Kamath A, et al. The dendritic cell populations of mouse lymph nodes [J]. J Immuuol,2001,167 (2) : 741-748.
  • 10Banchereau J, Steinman RM. Deneritic cell and the control of immunity[J]. Nature 1998, 392(6 673): 245-251.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部